Q-omics provides the consensus-scored RNU6-849P profile across patient tissues and cancer cell-line models. RNU6-849P expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in BLCA. Additionally, RNU6-849P RNA expression shows 5,943 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight BLCA, and ESCA as cancer lineages where RNU6-849P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RNU6-849P — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RNU6-849P survival associations across molecular data types. RNU6-849P RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-849P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	2	BLCA (45)	view →

This table ranks reproducible RNU6-849P RNA expression–survival associations across cancer types. High RNU6-849P expression shows unfavorable associations in BLCA and UCEC. The BLCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .018). Together, the overview and detailed table identify BLCA as the clearest survival context for RNU6-849P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.163	0.625	.018	45	view →
UCEC	DFS	Tertile	All	0.322	0.649	.004	36	view →

Pink = unfavorable, green = favorable. all 2 lineages →

RNU6-849P-BLCA (DFS)

Kaplan–Meier survival curve for RNU6-849P RNA expression in BLCA: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RNU6-849P in patient tissues and cancer cell lines. In patient samples, RNU6-849P shows the broadest associations at the RNA and protein expression levels, with ESCA recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	5,943	ESCA (2688)	view →
Function (RNA)	2,690	STAD (2672)	view →